CN105203771A - Serum amyloid protein A determination kit and use method thereof - Google Patents

Serum amyloid protein A determination kit and use method thereof Download PDF

Info

Publication number
CN105203771A
CN105203771A CN201510578749.9A CN201510578749A CN105203771A CN 105203771 A CN105203771 A CN 105203771A CN 201510578749 A CN201510578749 A CN 201510578749A CN 105203771 A CN105203771 A CN 105203771A
Authority
CN
China
Prior art keywords
liquid
reagent tube
detection liquid
add
detects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510578749.9A
Other languages
Chinese (zh)
Inventor
黄争上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHAOXING SHENGKANG BIOLOGY TECHNOLOGY Co Ltd
Original Assignee
SHAOXING SHENGKANG BIOLOGY TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHAOXING SHENGKANG BIOLOGY TECHNOLOGY Co Ltd filed Critical SHAOXING SHENGKANG BIOLOGY TECHNOLOGY Co Ltd
Priority to CN201510578749.9A priority Critical patent/CN105203771A/en
Publication of CN105203771A publication Critical patent/CN105203771A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention discloses a serum amyloid protein A determination kit and a use method thereof. The serum amyloid protein A determination kit comprises first detection liquid and second detection liquid, wherein the first detection liquid includes first detection liquid Tris-HCl buffer liquid and first detection liquid sodium azide, and the second detection liquid includes second detection liquid Tris-HCl buffer liquid, second detection liquid sodium azide and latex particles coated with anti-human serum amyloid protein A antibodies. According to the serum amyloid protein A determination kit and the use method of the serum amyloid protein A determination kit, by adopting latex-enhanced immunoturbidimetry, the operation is simple, the accuracy is high, and the popularization is facilitated.

Description

A kind of serum amyloid A protein measures kit and using method thereof
Technical field
The present invention relates to a kind of serum amyloid A protein and measure kit and using method thereof.
Background technology
Serum amyloid A protein (serumamyloidAprotein, SAA) is acute phase protein, and during inflammation, infectivity and noninfectious disease, its concentration in blood sharply can raise within a few hours, can be elevated to 1000 times of initial concentration; SAA and HDL is relevant, and it can regulate the metabolism of HDL between inflammatory phase, and the characteristic of a SAA particular importance is that its catabolite can be deposited in different organs in the fibriilar mode of amyloid A, and in chronic inflammatory diseases, this is a kind of serious complication; Serum amyloid A protein raises and also sees atherosclerotic, diabetic nephropathy, acute myocardial infarction AMI, coronary heart disease, chronic renal disease.In assess inflammation, monitor in its activity and treatment, SAA and CRP has similar effect.SAA detects and occurs, in virus infections, the patient (particularly carrying out the patient of immunosuppressive therapy) of kidney transplantation exclusion reaction and the cystic fibrosis patient of adrenocortical hormones in treating, to detect more conclusive than c reactive protein in diagnosis.Research finds, in the arthritic case of trouble, the relation of serum amyloid A protein and Disease Activity is the closest.Detection c reactive protein and serum amyloid A protein can improve the diagnostic sensitivity to infecting simultaneously.But current used to measure its accuracy of kit about serum amyloid A protein low, and complicated operation, not easily promote.
Summary of the invention
The object of the present invention is to provide a kind of serum amyloid A protein to measure kit and using method thereof, it is by latex enhancing immune turbidimetry, and simple to operate, accuracy is high, is convenient to promote.
In order to achieve the above object, technical scheme of the present invention is:
A kind of serum amyloid A protein measures kit, comprise the first detection liquid, second and detect liquid, first detects liquid comprises the first detection liquid Tris-HCl damping fluid, the first detection liquid sodium azide, the composition of each component is respectively by weight percentage: first detects liquid Tris-HCl damping fluid 97-99%, the first detects liquid sodium azide 1-3%; Second detection liquid comprises the second detection liquid Tris-HCl damping fluid, second and detects liquid sodium azide, is coated with the latex particle of AHS's amyloid A antibody, the composition of each component is respectively by weight percentage: second detects liquid Tris-HCl damping fluid 94-98%, second detects liquid sodium azide 1-3%, is coated with the latex particle 1-3% of AHS's amyloid A antibody.
First detects liquid comprises the first detection liquid Tris-HCl damping fluid, the first detection liquid sodium azide, and the composition of each component is respectively by weight percentage: first detects liquid Tris-HCl damping fluid 98%, first detects liquid sodium azide 2%; Second detection liquid comprises the second detection liquid Tris-HCl damping fluid, second and detects liquid sodium azide, is coated with the latex particle of AHS's amyloid A antibody, the composition of each component is respectively by weight percentage: second detects liquid Tris-HCl damping fluid 96%, second detects liquid sodium azide 2%, is coated with the latex particle 2% of AHS's amyloid A antibody.
Serum amyloid A protein measures a using method for kit, comprises the steps: first to prepare the first Reagent Tube, the second Reagent Tube, the 3rd Reagent Tube; Then in the first Reagent Tube, add the first detection liquid 250 μ L, distilled water 8 μ L mixes and hatches 5 minutes, in the second Reagent Tube, add the first detection liquid 250 μ L simultaneously, titer 8 μ L mixes and hatches 5 minutes, in the 3rd Reagent Tube, add the first detection liquid 250 μ L simultaneously, detect liquid 8 μ L and mix and hatch 5 minutes; Then in the first Reagent Tube, add the second detection liquid add 50 μ L and mix and hatch 1 minute, in the second Reagent Tube, add the second detection liquid add 50 μ L and mix and hatch 1 minute simultaneously, in the 3rd Reagent Tube, add the second detection liquid simultaneously add 50 μ L and mix and hatch 1 minute; Finally read the absorbance of the first Reagent Tube, the second Reagent Tube, the 3rd Reagent Tube respectively, absorbance is compared with the titer of concentration known, thus draw the content detecting serum amyloid A protein in liquid.
Described temperature when hatching is 37 DEG C.
Be coated with the latex particle of serum amyloid A protein (SAA) antibody, when mixing with the detection liquid containing SAA antigen, agglutinating reaction can occur, thus cause the change of absorbance, its size is proportional with SAA antigenic content in detection liquid.Absorbance change is compared with the titer of concentration known, quantitatively can draw the content detecting serum amyloid A protein in liquid.
The invention has the beneficial effects as follows: a kind of serum amyloid A protein measures kit and using method thereof, it is by latex enhancing immune turbidimetry, and simple to operate, accuracy is high, is convenient to promote.
Embodiment
Embodiment 1
A kind of serum amyloid A protein measures kit, comprise the first detection liquid, second and detect liquid, first detects liquid comprises the first detection liquid Tris-HCl damping fluid, the first detection liquid sodium azide, the composition of each component is respectively by weight percentage: first detects liquid Tris-HCl damping fluid 98%, first detects liquid sodium azide 2%; Second detection liquid comprises the second detection liquid Tris-HCl damping fluid, second and detects liquid sodium azide, is coated with the latex particle of AHS's amyloid A antibody, the composition of each component is respectively by weight percentage: second detects liquid Tris-HCl damping fluid 96%, second detects liquid sodium azide 2%, is coated with the latex particle 2% of AHS's amyloid A antibody.
Serum amyloid A protein measures a using method for kit, comprises the steps: first to prepare the first Reagent Tube, the second Reagent Tube, the 3rd Reagent Tube; Then in the first Reagent Tube, add the first detection liquid 250 μ L, distilled water 8 μ L mixes and hatches 5 minutes, in the second Reagent Tube, add the first detection liquid 250 μ L simultaneously, titer 8 μ L mixes and hatches 5 minutes, in the 3rd Reagent Tube, add the first detection liquid 250 μ L simultaneously, detect liquid 8 μ L and mix and hatch 5 minutes; Then in the first Reagent Tube, add the second detection liquid add 50 μ L and mix and hatch 1 minute, in the second Reagent Tube, add the second detection liquid add 50 μ L and mix and hatch 1 minute simultaneously, in the 3rd Reagent Tube, add the second detection liquid simultaneously add 50 μ L and mix and hatch 1 minute; Finally read the absorbance of the first Reagent Tube, the second Reagent Tube, the 3rd Reagent Tube respectively, absorbance is compared with the titer of concentration known, thus draw the content detecting serum amyloid A protein in liquid.Described temperature when hatching is 37 DEG C.
A kind of serum amyloid A protein of the present embodiment measures kit and using method thereof, and it is by latex enhancing immune turbidimetry, and simple to operate, accuracy is high, is convenient to promote.
Embodiment 2
A kind of serum amyloid A protein measures kit, comprise the first detection liquid, second and detect liquid, first detects liquid comprises the first detection liquid Tris-HCl damping fluid, the first detection liquid sodium azide, the composition of each component is respectively by weight percentage: first detects liquid Tris-HCl damping fluid 97%, first detects liquid sodium azide 3%; Second detection liquid comprises the second detection liquid Tris-HCl damping fluid, second and detects liquid sodium azide, is coated with the latex particle of AHS's amyloid A antibody, the composition of each component is respectively by weight percentage: second detects liquid Tris-HCl damping fluid 94%, second detects liquid sodium azide 3%, is coated with the latex particle 3% of AHS's amyloid A antibody.
Serum amyloid A protein measures a using method for kit, comprises the steps: first to prepare the first Reagent Tube, the second Reagent Tube, the 3rd Reagent Tube; Then in the first Reagent Tube, add the first detection liquid 250 μ L, distilled water 8 μ L mixes and hatches 5 minutes, in the second Reagent Tube, add the first detection liquid 250 μ L simultaneously, titer 8 μ L mixes and hatches 5 minutes, in the 3rd Reagent Tube, add the first detection liquid 250 μ L simultaneously, detect liquid 8 μ L and mix and hatch 5 minutes; Then in the first Reagent Tube, add the second detection liquid add 50 μ L and mix and hatch 1 minute, in the second Reagent Tube, add the second detection liquid add 50 μ L and mix and hatch 1 minute simultaneously, in the 3rd Reagent Tube, add the second detection liquid simultaneously add 50 μ L and mix and hatch 1 minute; Finally read the absorbance of the first Reagent Tube, the second Reagent Tube, the 3rd Reagent Tube respectively, absorbance is compared with the titer of concentration known, thus draw the content detecting serum amyloid A protein in liquid.Described temperature when hatching is 37 DEG C.
A kind of serum amyloid A protein of the present embodiment measures kit and using method thereof, and it is by latex enhancing immune turbidimetry, and simple to operate, accuracy is high, is convenient to promote.
Embodiment 3
A kind of serum amyloid A protein measures kit, comprise the first detection liquid, second and detect liquid, first detects liquid comprises the first detection liquid Tris-HCl damping fluid, the first detection liquid sodium azide, the composition of each component is respectively by weight percentage: first detects liquid Tris-HCl damping fluid 99%, first detects liquid sodium azide 1%; Second detection liquid comprises the second detection liquid Tris-HCl damping fluid, second and detects liquid sodium azide, is coated with the latex particle of AHS's amyloid A antibody, the composition of each component is respectively by weight percentage: second detects liquid Tris-HCl damping fluid 98%, second detects liquid sodium azide 1%, is coated with the latex particle 1% of AHS's amyloid A antibody.
Serum amyloid A protein measures a using method for kit, comprises the steps: first to prepare the first Reagent Tube, the second Reagent Tube, the 3rd Reagent Tube; Then in the first Reagent Tube, add the first detection liquid 250 μ L, distilled water 8 μ L mixes and hatches 5 minutes, in the second Reagent Tube, add the first detection liquid 250 μ L simultaneously, titer 8 μ L mixes and hatches 5 minutes, in the 3rd Reagent Tube, add the first detection liquid 250 μ L simultaneously, detect liquid 8 μ L and mix and hatch 5 minutes; Then in the first Reagent Tube, add the second detection liquid add 50 μ L and mix and hatch 1 minute, in the second Reagent Tube, add the second detection liquid add 50 μ L and mix and hatch 1 minute simultaneously, in the 3rd Reagent Tube, add the second detection liquid simultaneously add 50 μ L and mix and hatch 1 minute; Finally read the absorbance of the first Reagent Tube, the second Reagent Tube, the 3rd Reagent Tube respectively, absorbance is compared with the titer of concentration known, thus draw the content detecting serum amyloid A protein in liquid.Described temperature when hatching is 37 DEG C.
A kind of serum amyloid A protein of the present embodiment measures kit and using method thereof, and it is by latex enhancing immune turbidimetry, and simple to operate, accuracy is high, is convenient to promote.

Claims (4)

1. a serum amyloid A protein measures kit, it is characterized in that: comprise the first detection liquid, second and detect liquid, first detects liquid comprises the first detection liquid Tris-HCl damping fluid, the first detection liquid sodium azide, the composition of each component is respectively by weight percentage: first detects liquid Tris-HCl damping fluid 97-99%, the first detects liquid sodium azide 1-3%; Second detection liquid comprises the second detection liquid Tris-HCl damping fluid, second and detects liquid sodium azide, is coated with the latex particle of AHS's amyloid A antibody, the composition of each component is respectively by weight percentage: second detects liquid Tris-HCl damping fluid 94-98%, second detects liquid sodium azide 1-3%, is coated with the latex particle 1-3% of AHS's amyloid A antibody.
2. a kind of serum amyloid A protein according to claim 1 measures kit, it is characterized in that: first detects liquid comprises the first detection liquid Tris-HCl damping fluid, the first detection liquid sodium azide, the composition of each component is respectively by weight percentage: first detects liquid Tris-HCl damping fluid 98%, first detects liquid sodium azide 2%; Second detection liquid comprises the second detection liquid Tris-HCl damping fluid, second and detects liquid sodium azide, is coated with the latex particle of AHS's amyloid A antibody, the composition of each component is respectively by weight percentage: second detects liquid Tris-HCl damping fluid 96%, second detects liquid sodium azide 2%, is coated with the latex particle 2% of AHS's amyloid A antibody.
3. a kind of serum amyloid A protein according to claim 1 measures the using method of kit, it is characterized in that comprising the steps: first to prepare the first Reagent Tube, the second Reagent Tube, the 3rd Reagent Tube; Then in the first Reagent Tube, add the first detection liquid 250 μ L, distilled water 8 μ L mixes and hatches 5 minutes, in the second Reagent Tube, add the first detection liquid 250 μ L simultaneously, titer 8 μ L mixes and hatches 5 minutes, in the 3rd Reagent Tube, add the first detection liquid 250 μ L simultaneously, detect liquid 8 μ L and mix and hatch 5 minutes; Then in the first Reagent Tube, add the second detection liquid add 50 μ L and mix and hatch 1 minute, in the second Reagent Tube, add the second detection liquid add 50 μ L and mix and hatch 1 minute simultaneously, in the 3rd Reagent Tube, add the second detection liquid simultaneously add 50 μ L and mix and hatch 1 minute; Finally read the absorbance of the first Reagent Tube, the second Reagent Tube, the 3rd Reagent Tube respectively, absorbance is compared with the titer of concentration known, thus draw the content detecting serum amyloid A protein in liquid.
4. a kind of serum amyloid A protein according to claim 3 measures the using method of kit, it is characterized in that: described in temperature when hatching be 37 DEG C.
CN201510578749.9A 2015-09-14 2015-09-14 Serum amyloid protein A determination kit and use method thereof Pending CN105203771A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510578749.9A CN105203771A (en) 2015-09-14 2015-09-14 Serum amyloid protein A determination kit and use method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510578749.9A CN105203771A (en) 2015-09-14 2015-09-14 Serum amyloid protein A determination kit and use method thereof

Publications (1)

Publication Number Publication Date
CN105203771A true CN105203771A (en) 2015-12-30

Family

ID=54951556

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510578749.9A Pending CN105203771A (en) 2015-09-14 2015-09-14 Serum amyloid protein A determination kit and use method thereof

Country Status (1)

Country Link
CN (1) CN105203771A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105548571A (en) * 2016-02-02 2016-05-04 潍坊三维生物工程集团有限公司 Kit and method for detecting content of serum amyloid protein A and application
CN105929173A (en) * 2016-04-27 2016-09-07 深圳市国赛生物技术有限公司 Detection kit and detection method of serum amyloid A protein
CN106018829A (en) * 2016-06-22 2016-10-12 浙江达美生物技术有限公司 Testing reagent for serum amyloid protein A and preparation method of testing reagent
CN106290907A (en) * 2016-08-03 2017-01-04 宁波普瑞柏生物技术有限公司 Serum amyloid A protein quantitative detecting reagent and detection method in whole blood
CN106353507A (en) * 2016-08-24 2017-01-25 武汉生之源生物科技股份有限公司 Kit for detecting serum amyloid protein and application thereof
CN107015004A (en) * 2017-03-21 2017-08-04 深圳市汇松科技发展有限公司 A kind of serum amyloid A protein determines kit and preparation method thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105548571A (en) * 2016-02-02 2016-05-04 潍坊三维生物工程集团有限公司 Kit and method for detecting content of serum amyloid protein A and application
CN105929173A (en) * 2016-04-27 2016-09-07 深圳市国赛生物技术有限公司 Detection kit and detection method of serum amyloid A protein
CN106018829A (en) * 2016-06-22 2016-10-12 浙江达美生物技术有限公司 Testing reagent for serum amyloid protein A and preparation method of testing reagent
CN106290907A (en) * 2016-08-03 2017-01-04 宁波普瑞柏生物技术有限公司 Serum amyloid A protein quantitative detecting reagent and detection method in whole blood
CN106290907B (en) * 2016-08-03 2018-07-06 宁波普瑞柏生物技术股份有限公司 Serum amyloid A protein quantitative detecting reagent and detection method in whole blood
CN106353507A (en) * 2016-08-24 2017-01-25 武汉生之源生物科技股份有限公司 Kit for detecting serum amyloid protein and application thereof
CN107015004A (en) * 2017-03-21 2017-08-04 深圳市汇松科技发展有限公司 A kind of serum amyloid A protein determines kit and preparation method thereof

Similar Documents

Publication Publication Date Title
CN105203771A (en) Serum amyloid protein A determination kit and use method thereof
Samsudin et al. Clinical utility and measurement of procalcitonin
Li et al. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition
Bissonnette et al. A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis
Riedel Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis
Li et al. Elevated circulating VE-cadherin+ CD144+ endothelial microparticles in ischemic cerebrovascular disease
Sandkovsky et al. The use and value of procalcitonin in solid organ transplantation
Purevdorj et al. Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura
Makris et al. Neutrophil gelatinase-associated lipocalin in acute kidney injury
CN102662064A (en) Immunonephelometry kit for detecting lipid carrier protein related to neutrophils gelatinase and preparation method thereof
CN103454425A (en) Reagent strip for detecting PCT (procalcitonin) and preparation method of reagent strip
CN106018299A (en) Kit for measuring serum amyloid A and preparation method of kit
CN103454193A (en) Immunoturbidimetric kit for detecting lipoprotein (a) and preparation method thereof
CN102628866B (en) Liquid double reagent kit for determining ferritin in serum by utilization of IGY ferritin antibody through latex enhanced turbidimetric immunoassay
JP2013527437A5 (en)
CN106053862B (en) Serum amyloid A protein(SAA)Determine kit
CN103454431A (en) Immunoturbidimetric kit for detecting beta2-microglobulin and preparation method thereof
Berezin et al. Impaired phenotype of circulating endothelial microparticles in chronic heart failure patients: relevance to body mass index
Behrens et al. Extracellular vesicles as regulators of kidney function and disease
CN105699665A (en) Detection kit of lipocalin related to neutrophil gelatinase
Wolide et al. Association between thyroid hormone parameters and dyslipidemia among type 2 diabetes mellitus patients: Comparative cross-sectional study
CN106290902A (en) A kind of colloidal-gold detecting-card of serum amyloid A protein 1 and preparation method thereof
Kamel et al. The potential use of urinary transferrin, urinary adiponectin, urinary Retinol Binding Protein, and serum zinc alpha 2 glycoprotein levels as novel biomarkers for early diagnosis of diabetic nephropathy: a case-control study
CN103645321A (en) Test paper for screening procalcitonin and preparation method of test paper
Feng et al. Plasma levels of monokine induced by interferon-gamma/chemokine (CXX motif) ligand 9, thymus and activation-regulated chemokine/chemokine (CC motif) ligand 17 in children with Kawasaki disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151230